TRKB tyrosine kinase receptor is a potential therapeutic target for poorly differentiated oral squamous cell carcinoma

It has been reported that one of the neurotrophin receptors, tropomyosin receptor kinase B (TRKB), is frequently overexpressed in various tumor tissues including oral squamous cell carcinoma (OSCC), and that its upregulation promotes tumor progression in human cancers. However, the correlation betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriwaki, Kazumasa, Ayani, Yusuke, Kuwabara, Hiroko, Terada, Tetsuya, Kawata, Ryo, Asahi, Michio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982746/
https://www.ncbi.nlm.nih.gov/pubmed/29861866
http://dx.doi.org/10.18632/oncotarget.25396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982746/
https://www.ncbi.nlm.nih.gov/pubmed/29861866
http://dx.doi.org/10.18632/oncotarget.25396

Ejemplares similares